Navigation Links
Positive results from placebo-controlled phase IIa study in,patients suffering from house dust mite allergy

tients treated so far with QbG10 in the different studies, we can see the following
picture: QbG10 seems to be active as a monotherapy; however, combination with an allergen extract
at a standard dose appears to enhance the therapeutic effect. The highest efficacy was achieved
when QbG10 was combined with a dose of allergen extract usually applied in conventional
desensitization therapy, i.e. a 10-times higher dose than the one tested in this present study. In a
next clinical trial we will test higher doses of CYT003-QbG10 monotherapy and compare the safety
and efficacy profile directly with the most promising product formulations of CYT005-AllQbG10 in
order to select the best product candidate for late stage development.”

CYT003-QbG10 Conference Call and Webcast
Cytos Biotechnology will host a conference call and Q&A session today, Tuesday, May 15, 2007 at
10 am (CET) to discuss the study findings.
To access the conference call, please dial the following numbers:
Europe +41 91 610 56 00
U.S. +1 866 291 41 66
U.K. +44 207 107 06 11

The conference call will be held in English and will also be accessible by webcast on the internet.
You may follow the call live or have it replayed later on demand. To access the webcast and the
presentation, please follow the link provided on our homepage www.cytos.com. The presentation
slides will be available for download 30 minutes prior to the conference call.

Among other projects, Cytos Biotechnology will also discuss its allergy program at the company’s
upcoming R&D day on Wednesday, June 20, 2007 at 2 pm (CET) at the company’s premises in
Schlieren.

About the phase IIa study and the analysis
The multi-centre, randomized, double-blind and placebo-controlled phase IIa study included 40 male'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:3/27/2015)... Across the global healthcare landscape, the Medical ... development, market education, and regulatory compliance. As emerging markets ... is expected to increase in prominence and follow the ... to research by benchmarking firm, Best Practices, LLC, all ... Medical Affairs. Among companies in India ...
(Date:3/27/2015)... 2015 Levi & Korsinsky announces it has ... OHRP ) concerning possible violations of federal securities laws. ... in connection with its study of the drug OHR-102. ... or contact Joseph E. Levi, Esq. either ... at (212) 363-7500, toll-free: (877) 363-5972. Levi ...
(Date:3/27/2015)... -- Dynatronics Corporation (NASDAQ: DYNT ) today announced that ... Company,s Board of Directors effective March 23, 2015, to fill ... board member Joseph Barton .  "The ... Directors represents an important step forward for the company," said ... "Rich is a proven leader and is well-known for his ...
Breaking Medicine Technology:Medical Affairs Capabilities Expanding in Emerging Marketplaces 2Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2
... , , CONCORD, Calif. , Feb. 3 ... covering most of the Western United States . Effective February 1, ... been granted an exclusive sales territory encompassing the states of California ... Nevada , Oregon , Washington , Colorado , Utah ...
... , VIENNA, Va. , Feb. ... that Geert Kersten , Chief Executive Officer, will be presenting ... Biotechnology Industry Organization (BIO), the conference will take place February ... Mr. Kersten,s presentation will be on Tuesday, February 9th , ...
Cached Medicine Technology:Pulse Systems Announces New Sales Representation in the Western United States 2Pulse Systems Announces New Sales Representation in the Western United States 3CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference 2
(Date:3/28/2015)... 28, 2015 Take a bite of ... into action. Acids tumble into the stomach, ready to ... valve-like structure lets these acids run amok, triggering a ... common symptom. More than 60 million Americans have heartburn ... where heartburn starts, and how it can be stopped. ...
(Date:3/28/2015)... York (PRWEB) March 28, 2015 ... involving devices manufactured by C.R. Bard, Inc. continue ... in U.S. District Court, Southern District of West ... is serving on the Plaintiffs’ Steering Committee. ... Court has granted certain defendants named in those ...
(Date:3/28/2015)... 2015 Emergency Medical Care (EMC), a ... Manhattan, recently commemorated its three-year anniversary of being the ... addition to 24-hour urgent care, Emergency Medical Care offers ... this time, Emergency Medical Care’s Urgent Care NYC ... pain, eye injuries, ear infections, fevers, insect bites, burns, ...
(Date:3/28/2015)... New York, NY (PRWEB) March 28, 2015 ... 2015 highlighted a problem which could prove critical to ... Why system testing, a critical aspect of data security, ... payment card industry data security report, every major category ... vulnerability scanning and penetration testing. “With all the craziness ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Pitching speed, player’s ... history of shoulder and elbow injuries, according to new research ... ( AOSSM ) Specialty Day. , “Our findings indicate that ... 20% increase in likelihood of a history of injury, a ... a 12% increase likelihood of a history of injury, and ...
Breaking Medicine News(10 mins):Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2
... among the children gets kicked off, with the government ... children will be weighed and provided nutrition diet. // ... Sanjivani Abhiyan (Child Growth Monitoring Drive), were launched by ... Bangadda village in Indore district. ,"The ...
... biological father of his child) has always been a topic ... detailed discussion by anthropologists. // A new study, by Kermyt ... Social Research) that would be published in the June 06 ... On how accurate are men's suspicions of whether or not ...
... being the leading cause of cancer deaths in the world ... that includes more than 37,000 in the UK itself! ... lung cancer, owes its birth to the impairment of a ... in Nashville, have expressed optimism with this finding, which will ...
... particular diet can influence corrective behaviour in prisoners.// ... a product of poor nutrition was tested in a ... become less violent when put on a diet rich ... seafood.,The paper titled “Seafood Consumption and Homicide Mortality”, raised ...
... out to carry out tests to determine the efficacy of ... on Sunday. The program designed to study 40 heart patients ... Sciences, Mahidol University and the Cardiac Institute of Thailand. ... Department, said Thailand did not have any guidelines on this ...
... of genes that are safely ensconced in the systematic pattern of ... genes in the human genome are in an alert state in ... dormant state. ,This trait of genes, called gene silencing ... cover for the genome from viruses, and even cancer, and is ...
Cached Medicine News:Health News:Drive Against Malnutrition Among Children In MP Gets Kicked Off 2Health News:Can Men Gauge Biological Paternity Accurately 2Health News:Novel method conceived, to achieve genome-wide gene silencing. 2
... The many benefits of fibre bronchoscopy: The ... by which all other fibre bronchoscopes are ... bronchoscopes from PENTAX, including the FB-19TV, FB-18V ... slim FB-10V and the pediatric FB-8V, offer ...
... many benefits of fibre bronchoscopy: The HF-compatible ... which all other fibre bronchoscopes are measured., ... from PENTAX, including the FB-19TV, FB-18V and ... FB-10V and the pediatric FB-8V, offer much ...
... benefits of fibre bronchoscopy: The HF-compatible V ... all other fibre bronchoscopes are measured., ... PENTAX, including the FB-19TV, FB-18V and FB-15V ... and the pediatric FB-8V, offer much better ...
... fiberoptic bronchoscopes offers a ... with a slim outside ... allows for improved suction ... cytology brushes. The scope ...
Medicine Products: